SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-17-002210
Filing Date
2017-04-21
Accepted
2017-04-21 16:38:59
Documents
6
Period of Report
2017-04-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_041817.htm 8-K 37870
2 UNDERWRITING AGREEMENT ex-1_1.htm EX-1.1 245782
3 LEGAL OPINION ex-5_1.htm EX-5.1 9564
4 PRESS RELEASE ex-99_1.htm EX-99.1 13678
5 PRESS RELEASE ex-99_2.htm EX-99.2 11913
6 GRAPHIC prerelanncomt001.jpg GRAPHIC 13732
  Complete submission text file 0001387131-17-002210.txt   339138
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 17776346
SIC: 2834 Pharmaceutical Preparations